Assessment of Changes in Dipeptidyl-peptidase-IV (DPP-IV) Enzyme Activity in Type 1 and Type 2 Diabetes

被引：0
|
作者：
Stevenson, C. L. [1 ]
Abdel-Wahab, Y. H. A. [1 ]
O'Kane, M. J. [2 ]
McKillop, A. M. [1 ]
机构：
[1] Univ Ulster, Sch Biomed Sci, SAAD Ctr Pharm & Diabet, Coleraine BT52 1SA, Londonderry, North Ireland
[2] Altnagelvin Hosp, Derry BT47 6SB, Londonderry, North Ireland
来源：
IRISH JOURNAL OF MEDICAL SCIENCE | 2012年 / 181卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S344 / S344
页数：1
相关论文
共 50 条
  • [21] Effect of MK-0431, a dipeptidyl peptidase IV (DPP-IV) inhibitor, on glycemic control after 12 weeks in patients with type 2 diabetes
    Herman, G
    Hanefeld, M
    Wu, M
    Chen, X
    Zhao, P
    Stein, P
    DIABETES, 2005, 54 : A134 - A134
  • [22] Effect of renal insufficiency on the pharmacokinetics of MK-0431 (sitagliptin), a selective dipeptidyl-peptidase-IV (DPP-IV) inhibitor.
    Bergman, AJ
    Cote, J
    Yi, B
    Wang, AQ
    Zeng, W
    Chen, L
    Marbury, T
    Swan, S
    Smith, W
    Gottesdiener, KM
    Wagner, JA
    Herman, GA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P75 - P75
  • [23] Effect of MK-0431, a dipeptidyl peptidase IV (DPP-IV) inhibitor, on glycemic control after 12 weeks in patients with type 2 diabetes
    Hanefeld, M
    Herman, G
    Mickej, C
    McGowan, A
    Wu, M
    Zhao, P
    Stein, P
    DIABETOLOGIA, 2005, 48 : A287 - A287
  • [24] Do Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Cause Heart Failure?
    Clifton, Peter
    CLINICAL THERAPEUTICS, 2014, 36 (12) : 2072 - 2079
  • [25] Topical administration of dipeptidyl peptidase IV (DPP-IV) inhibitors prevents retinal neurodegeneration in experimental diabetes
    Hernandez, Cristina
    Bogdanov, Patricia
    Sola-Adell, Cristina
    Sampedro, Joel
    Valeri, Marta
    Simo-Servat, Olga
    Herance, Raul
    Simo, Rafael
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [26] TOPICAL ADMINISTRATION OF DIPEPTIDYL PEPTIDASE IV (DPP-IV) INHIBITORS PREVENTS RETINAL NEURODEGENERATION IN EXPERIMENTAL DIABETES
    Hernandez, C.
    Bogdanov, P.
    Sola-Adell, C.
    Sampedro, J.
    Simo-Servat, O.
    Garcia-Ramirez, M.
    Simo, R.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2017, 27 (03) : E113 - E113
  • [27] Analysis of the Structure and Activity of Dipeptidyl Peptidase IV (DPP-IV) Inhibitory Oligopeptides from Sorghum Kafirin
    Dai, Lingyan
    Kong, Lingxin
    Cai, Xiao
    Jiang, Peng
    Liu, Nian
    Zhang, Dongjie
    Li, Zhijiang
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2022, 70 (06) : 2010 - 2017
  • [28] Sitagliptin (MK-0431), a selective dipeptidyl-peptidase-IV (DPP-IV) inhibitor, does not affect the pharmacokinetics of simvastatin in humans.
    Bergman, AJ
    Cote, J
    Maes, A
    Zhao, J
    Roadcap, B
    Sun, L
    Valesky, R
    Yang, A
    Keymeulen, B
    Wagner, JA
    Herman, GA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P48 - P48
  • [29] Identification and dipeptidyl peptidase IV (DPP-IV) inhibitory activity verification of peptides from mouse lymphocytes
    Wang, Juan
    Xie, Yujia
    Luan, Yuanyuan
    Guo, Tingting
    Xiao, Shanshan
    Zeng, Xingxing
    Zhang, Shaohui
    FOOD SCIENCE AND HUMAN WELLNESS, 2022, 11 (06) : 1515 - 1526
  • [30] Elevated Dipeptidyl Peptidase IV (DPP-IV) Activity in Plasma from Patients with Various Lysosomal Diseases
    Lugowska, Agnieszka
    Baydakova, Galina
    Ilyushkina, Alex
    Zakharova, Ekaterina
    Mierzewska, Hanna
    Szymanska, Krystyna
    Wierzba, Jolanta
    Kubalska, Jolanta
    Graban, Alla
    Kmiec, Tomasz
    Perkowska-Sumila, Barbara
    Tylki-Szymanska, Anna
    Bednarska-Makaruk, Malgorzata
    DIAGNOSTICS, 2021, 11 (02)
12345